JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ALE
1976
DELISTED
Allete
ALE
| $10.8M | ﹤0.01% |
131,783
+12,521
| +10% | +$1.03M |
2015 Q4
14 quarters
|
|
|
BMCH
1977
DELISTED
BMC Stock Holdings, Inc
BMCH
| $10.8M | ﹤0.01% |
513,065
+411,462
| +405% | +$8.54M |
2017 Q4
6 quarters
|
|
1978
CALL
Dollar Tree
DLTR
$21.7B
| $10.8M | ﹤0.01% |
+100,000
| New | +$10.5M |
2019 Q2
0 quarters
|
|
1979
CALL
Thermo Fisher Scientific
TMO
$253B
| $10.8M | ﹤0.01% |
36,700
-600
| -2% | -$165K |
2018 Q2
4 quarters
|
|
1980
Carvana
CVNA
$46.3B
| $10.8M | ﹤0.01% |
867,520
+825,965
| +1,988% | +$10.6M |
2017 Q2
8 quarters
|
|
1981
CALL
Analog Devices
ADI
$204B
| $10.7M | ﹤0.01% |
94,900
| – | – |
2018 Q2
4 quarters
|
|
1982
Sony
SONY
$139B
| $10.7M | ﹤0.01% |
1,014,585
-1,526,290
| -60% | -$15M |
2013 Q2
24 quarters
|
|
|
MAG
1983
DELISTED
MAG Silver
MAG
| $10.6M | ﹤0.01% |
998,169
-24,293
| -2% | -$244K |
2015 Q4
14 quarters
|
|
1984
iShares Morningstar Growth ETF
ILCG
$3.31B
| $10.6M | ﹤0.01% |
278,230
-5,615
| -2% | -$210K |
2013 Q2
24 quarters
|
|
1985
Powell Industries
POWL
$7.43B
| $10.6M | ﹤0.01% |
853,020
-2,229
| -0.3% | -$24.8K |
2015 Q4
14 quarters
|
|
1986
CALL
Molina Healthcare
MOH
$10.2B
| $10.6M | ﹤0.01% |
+75,000
| New | +$10.3M |
2019 Q2
0 quarters
|
|
|
HDV
1987
iShares Core High Dividend ETF
HDV
$14.7B
| $10.6M | ﹤0.01% |
562,705
+163,105
| +41% | +$3.06M |
2013 Q2
24 quarters
|
|
1988
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$18.2B
| $10.6M | ﹤0.01% |
104,050
-3,115
| -3% | -$316K |
2013 Q2
24 quarters
|
|
1989
PUT
Cognizant
CTSH
$26.4B
| $10.6M | ﹤0.01% |
167,800
+20,000
| +14% | +$1.31M |
2017 Q1
9 quarters
|
|
|
SWN
1990
DELISTED
Southwestern Energy Company
SWN
| $10.5M | ﹤0.01% |
3,434,874
+873,379
| +34% | +$3.39M |
2013 Q2
24 quarters
|
|
1991
CALL
Wells Fargo
WFC
$247B
| $10.5M | ﹤0.01% |
226,800
-375,800
| -62% | -$17.6M |
2014 Q3
19 quarters
|
|
1992
Iovance Biotherapeutics
IOVA
$6.27B
| $10.5M | ﹤0.01% |
464,176
+19,532
| +4% | +$294K |
2017 Q2
8 quarters
|
|
1993
CALL
Travelers Companies
TRV
$75.3B
| $10.5M | ﹤0.01% |
70,200
| – | – |
2017 Q3
7 quarters
|
|
1994
PUT
Chemours
CC
$2.12B
| $10.5M | ﹤0.01% |
+420,000
| New | +$12.4M |
2019 Q2
0 quarters
|
|
1995
TriCo Bancshares
TCBK
$1.67B
| $10.4M | ﹤0.01% |
275,901
-122,664
| -31% | -$4.79M |
2014 Q4
18 quarters
|
|
1996
PUT
General Mills
GIS
$17.1B
| $10.4M | ﹤0.01% |
+199,800
| New | +$10.3M |
2019 Q2
0 quarters
|
|
|
BPMC
1997
DELISTED
Blueprint Medicines
BPMC
| $10.4M | ﹤0.01% |
112,517
+1,143
| +1% | +$94.3K |
2015 Q2
16 quarters
|
|
1998
Barnes & Noble Education
BNED
$403M
| $10.4M | ﹤0.01% |
30,139
+886
| +3% | +$340K |
2015 Q3
15 quarters
|
|
1999
Qualys
QLYS
$7.04B
| $10.4M | ﹤0.01% |
121,833
-11,421
| -9% | -$985K |
2014 Q2
20 quarters
|
|
2000
Saic
SAIC
$5.31B
| $10.4M | ﹤0.01% |
122,107
-113,368
| -48% | -$8.89M |
2013 Q4
22 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.